This is the promise of microneedle patches (MNP), which are essentially what they sound like. These would also have uses in diagnostics that might one day obliviate the need for drawing blood.
Delft-based uPATCH, a health-tech startup, has secured seed funding from INZET, a fund managed by Shaping Impact Group, to further its mission of advancing global drug delivery through microneedle ...
TORONTO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of ...